Article
Probabilistic Mixture Models Improve Calibration of Panel-derived Tumor Mutational Burden in the Context of both Tumor-normal and Tumor-only Sequencing.
Cancer research communications - 1 Mar 2023
Anaya Jordan, Sidhom John-William, Cummings Craig A, Baras Alexander S
Abstract excerpt
Background: Tumor mutational burden (TMB) has been investigated as a biomarker for immune checkpoint blockade (ICB) therapy. Increasingly, TMB is being estimated with gene panel-based assays (as opposed to full exome sequencing) and different gene panels cover overlapping but distinct genomic coordinates, making comparisons across panels difficult. Previous studies have suggested that standardization and...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
